Use of Erythropoietin in Patients with Multiple Myeloma

Publisher： Karger

E-ISSN： 2296-5262|26|1|80-84

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.26, Iss.1, 2003-03, pp. : 80-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recombinant Human Erythropoietin Is Associated with Increased Overall Survival in Patients with Multiple Myeloma

By  

Acta Haematologica, Vol. 117, Iss. 3, 2006-12 ,pp. : 162-167

Karger

Access to resources Recommend Favorite

A Systematic Review on the Use of Bortezomib in Multiple Myeloma Patients with Renal Impairment: What Is the Published Evidence?

By  

Acta Haematologica, Vol. 126, Iss. 3, 2011-07 ,pp. : 163-168

Karger

Access to resources Recommend Favorite

The effects of bortezomib on bone disease in patients with multiple myeloma

By  

CANCER, Vol. 120, Iss. 5, 2014-03 ,pp. : 618-623

John Wiley & Sons Inc

Access to resources Recommend Favorite

MULTIPLE MYELOMA: ALMOST ALL PATIENTS ARE CYTOGENETICALLY ABNORMAL

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 7-1048, Iss. 2, 1996-08 ,pp. : 217-227

John Wiley & Sons Inc

Access to resources Recommend Favorite

MULTIPLE MYELOMA: ALMOST ALL PATIENTS ARE CYTOGENETICALLY ABNORMAL

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 2, 1996-08 ,pp. : 217-227

John Wiley & Sons Inc

Access to resources Recommend Favorite